Jonathan Karush 10/5/26 Jonathan Karush 10/5/26

Republicans and Democrats find a unifying target: Pharmacy benefit managers

National Public Radio

Jonathan Karush 9/29/26 Jonathan Karush 9/29/26

4 largest PBMs control 75% of U.S. market, AMA finds

Fierce Healthcare

Jonathan Karush 9/28/26 Jonathan Karush 9/28/26

Bipartisan backlash against PBMs grows as critics target vertical integration by chains

WE NEWS

Jonathan Karush 4/7/26 Jonathan Karush 4/7/26

PBM formulary exclusions top 600 drugs amid pricing shift

Becker’s Hospital Review

Jonathan Karush 3/25/26 Jonathan Karush 3/25/26

A single bill could make CVS choose between its stores and its pharmacy benefit manager

Boston Globe

Jonathan Karush 1/14/26 Jonathan Karush 1/14/26

Congress: Reform PBMs to Lower Drug Costs for Hard-Working Americans

Real Clear Health

Jonathan Karush 10/23/25 Jonathan Karush 10/23/25

580,000 in Massachusetts live in ‘pharmacy deserts,’ new report shows

Boston Globe

Jonathan Karush 10/20/25 Jonathan Karush 10/20/25

Patients Not PBMs Coalition Renews Public Push for Legislative Action to Reform PBMs

Press Release

Jonathan Karush 9/24/25 Jonathan Karush 9/24/25

Drug Middlemen Aim to Avoid New Rules with Voluntary Changes

Bloomberg

Jonathan Karush 9/16/25 Jonathan Karush 9/16/25

Why your local pharmacy might be the next to disappear as Massachusetts has lost nearly 300 since 2010

Mass Live

Jonathan Karush 8/4/25 Jonathan Karush 8/4/25

PBMs concentrate market share across the nation: AMA

Medical Economics

Jonathan Karush 8/1/25 Jonathan Karush 8/1/25

Top 3 PBMs Contribute to Over 1500% Increase in Formulary Exclusions Since 2014

Drug Topics

Jonathan Karush 7/28/25 Jonathan Karush 7/28/25

Exclusive: House Oversight widens PBM inquiry

Axios

Jonathan Karush 5/27/25 Jonathan Karush 5/27/25

Suffering with chronic pain made worse by the health care system

Plymouth Independent

Jonathan Karush 3/28/25 Jonathan Karush 3/28/25

Big Pharma, big business, and larger questions

The Boston Globe

Jonathan Karush 1/27/25 Jonathan Karush 1/27/25

‘Knock out the middlemen’: A campaign promise Donald Trump should keep

The Boston Globe

Jonathan Karush 1/15/25 Jonathan Karush 1/15/25

US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain

Reuters

Jonathan Karush 11/6/24 Jonathan Karush 11/6/24

GoodRx, PBMs accused of suppressing reimbursements to independent pharmacies

Reuters

Jonathan Karush 10/19/24 Jonathan Karush 10/19/24

The Powerful Companies Driving Local Drugstores Out of Business

New York Times

Jonathan Karush 7/18/24 Jonathan Karush 7/18/24

Patients Not PBMs Coalition Calls Attention to Recent FTC Report on How PBMs Inflate Drug Costs and Squeeze Main Street Pharmacies

Coalition releases new digital ad, “Our Moment” and video recap of recent press conference on State House steps